In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites
STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath – a European multicenter clinical study evaluating performance of INIFY[®] Prostate in routine clinical practice – were presented at the European Congress of Pathology by Dr. Jordi Temprana Salvador from Vall d’Hebron in Barcelona. The study was performed at four sites: Cannizzaro Hospital, Catania, Italy; Linköping University Hospital, Linköping, Sweden; Hospital